Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Pros and Cons of Using Elderberry (Sambucus Nigra) for Prevention and Treatment of Covid-19 Publisher

Summary: A study suggests elderberry may help prevent viral infections like COVID-19 but could risk immune overreaction, needing more research. #COVID19 #HerbalMedicine

Asgary S1 ; Pouramini A2
Authors

Source: Advanced Biomedical Research Published:2022


Abstract

Background: The novel severe acute respiratory syndrome coronavirus 2 emerged in 2019. Health-care systems around the world are looking for alternative prevention and treatment remedies. Herbal supplements are popular among consumers as a complementary method to prevent and treat illnesses. One of them is Sambucus nigra. Methods: We searched for related articles in Scopus, Web of Science, PubMed, Google Scholar, and the Directory of Open Access Journals using the following keywords: elderberry, S. nigra, and COVID-19. Results: Elderberry has antiviral properties due to its ability to modulate inflammatory cytokines. The current evidence suggests elderberry is appropriate for the prevention and initial treatment of viral disease. Concerns have been raised that elderberry may overstimulate the immune system, increasing the risk of a cytokine storm. There is not yet enough evidence to support this claim. Conclusions: For COVID-19 patients, further research is required since elderberry may provoke a cytokine storm if administered therapeutically. © 2022 National Journal of Clinical Anatomy | Published by Wolters Kluwer - Medknow.
Other Related Docs
10. Spices and Biomarkers of Covid-19: A Mechanistic and Therapeutic Perspective, Advances in Experimental Medicine and Biology (2023)
15. Novel Drug Design for Treatment of Covid-19: A Systematic Review of Preclinical Studies, Canadian Journal of Infectious Diseases and Medical Microbiology (2022)
19. Curcumin and Piperine in Covid-19: A Promising Duo to the Rescue?, Advances in Experimental Medicine and Biology (2021)